Modern Authentication of Pharmaceuticals Act of 2025
Rep. Davis Introduces Bipartisan Bill to Add Chemical Trackers to Prescription Pills to Fight Counterfeits
The Modern Authentication of Pharmaceuticals Act of 2025 is currently in the early stages of the legislative process. It was recently introduced and sent to the House Committee on Energy and Commerce for review. There are no upcoming votes scheduled at this time, and the bill is still waiting for committee action.
Legislative Progress
While the bill has support from both parties, most standalone bills struggle to get a full vote in Congress unless they are part of a larger package.
Key Points
Impact Analysis
Personal Impact
Life & Work
Independent pharmacies and small pharmaceutical distributors would need to invest in new verification equipment capable of reading chemical identifiers. While this adds cost and complexity, it also gives small pharmacies a tool to verify drug authenticity, which could help them compete by offering stronger safety assurances to customers.
“determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).”
Disabilities
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Sponsor introductory remarks on measure. (CR H519)
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Modern Authentication of Pharmaceuticals Act of 2025
Data Sources
Sponsor
Cosponsors
(3)Analysis generated by AI. Always verify with official sources.